COSCIENS Biopharma (CSCI) Net Margin

Annual Net Margin

-48.89%
-72.24%-309.38%

December 1, 2023

Summary

Performance

1-Year Change

-309.38%

3-Year Change

-498.45%

5-Year Change

-1697.43%

15-Year Change

-559.78%

CSCI Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.93%
CSCI annual net profit margin is higher than 53.93% of companies in Healthcare sector

High & Low

All-time High

46.14%
CSCI annual net profit margin is currently -205.96% below its historical high of 46.14%

3-Year Low

-48.89%
CSCI annual net profit margin is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CSCI previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CSCI next annual earnings announcement has not yet been scheduled

OtherCSCIprofitabilitymetrics:

Annual Net Income

-$3.55 M
CSCI annual net profit is -$3.55 million

Annual Revenue

$7.26 M
CSCI annual revenue is $7.26 million

Annual Gross Margin

41.07%
CSCI annual gross profit margin is 41.07%

Annual EPS

-$1.92
CSCI annual earnings per share is -$1.92

Quarterly Net Margin

-307.59%
-246.74%-405.49%

September 1, 2024

Summary

Performance

3-Month Change

-405.49%

1-Year Change

-151.59%

3-Year Change

-151.59%

5-Year Change

-151.59%

CSCI Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.03%
CSCI quarterly net profit margin is higher than 25.03% of companies in Healthcare sector

High & Low

All-time High

71.45%
CSCI quarterly net profit margin is currently -530.50% below its historical high of 71.45%

3-Year Low

-307.59%
CSCI quarterly net profit margin is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIprofitabilitymetrics:

Quarterly Net Income

-$5.75 M
CSCI quarterly net profit is -$5.75 million

Quarterly Revenue

$1.87 M
CSCI quarterly revenue is $1.87 million

Quarterly Gross Margin

51.15%
CSCI quarterly gross profit margin is 51.15%

Quarterly EPS

-$1.85
CSCI quarterly earnings per share is -$1.85

Net Margin Formula

Net Margin =  Net Income
Revenue ✕ 100%

Annual Net Margin

-48.89%
CSCI annual net profit margin is -48.89%

Annual Net Income

-$3.55 M
CSCI annual net profit is -$3.55 million

Annual Revenue

$7.26 M
CSCI annual revenue is $7.26 million

CSCI Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-309.4%-151.6%
3 y3 years-498.4%-151.6%
5 y5 years-1697.4%-151.6%

CSCI Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-309.4%at low-944.3%at low
5 y5-year-309.4%at low-944.3%at low
alltimeall time-206.0%+98.6%-530.5%+95.8%

COSCIENS Biopharma Net Margin History

DateAnnualQuarterly
Sep 2024
-
-307.59%(+405.5%)
Jun 2024
-
-60.85%(-10.7%)
Mar 2024
-
-68.14%(-44.3%)
Dec 2023
-48.89%(-309.4%)
-122.26%(+207.6%)
Sep 2023
-
-39.75%(-35.7%)
Jun 2023
-
-61.78%(+460.6%)
Mar 2023
-
-11.02%(+94.0%)
Dec 2022
23.35%(+19.3%)
-5.68%(-121.6%)
Sep 2022
-
26.28%(-19.9%)
Jun 2022
-
32.82%(+11.7%)
Mar 2022
-
29.38%(-19.4%)
Dec 2021
19.57%(+59.5%)
36.43%(+88.3%)
Sep 2021
-
19.35%(+26.1%)
Jun 2021
-
15.34%(+40.1%)
Mar 2021
-
10.95%(-184.8%)
Dec 2020
12.27%(-239.6%)
-12.91%(-334.3%)
Sep 2020
-
5.51%(-76.1%)
Jun 2020
-
23.08%(-12.4%)
Mar 2020
-
26.35%(+579.1%)
Dec 2019
-8.79%(+223.2%)
3.88%(-209.0%)
Sep 2019
-
-3.56%(-80.5%)
Jun 2019
-
-18.29%(-8.1%)
Mar 2019
-
-19.91%(-267.5%)
Dec 2018
-2.72%(-63.3%)
11.89%(-184.6%)
Sep 2018
-
-14.06%(+131.6%)
Jun 2018
-
-6.07%(-53.3%)
Mar 2018
-
-13.01%(-77.7%)
Dec 2017
-7.41%(-128.0%)
-58.30%(-810.1%)
Sep 2017
-
8.21%(-29.6%)
Jun 2017
-
11.67%(+1983.9%)
Mar 2017
-
0.56%(-74.4%)
Dec 2016
26.47%(-42.6%)
2.19%(-89.8%)
Sep 2016
-
21.38%(-45.5%)
Jun 2016
-
39.25%(+31.4%)
Mar 2016
-
29.86%(-8.7%)
Dec 2015
46.14%(+157.3%)
-
Sep 2015
-
32.69%(+21.3%)
Jun 2015
-
26.96%(-338.4%)
Mar 2015
-
-11.31%(-654.4%)
Dec 2014
17.93%(+566.5%)
2.04%(-92.8%)
Sep 2014
-
28.22%(+8.9%)
Jun 2014
-
25.91%(+185.4%)
Mar 2014
-
9.08%(-207.8%)
Dec 2013
2.69%(-125.8%)
-8.42%(-236.5%)
Sep 2013
-
6.17%(-124.8%)
Jun 2013
-
-24.87%(-222.6%)
Mar 2013
-
20.28%(-200.3%)
Dec 2012
-10.42%(-204.4%)
-20.22%(+90.0%)
Sep 2012
-
-10.64%(-1.2%)
Jun 2012
-
-10.77%(+3490.0%)
Mar 2012
-
-0.30%(-101.9%)
Dec 2011
9.98%(+20.0%)
15.87%(-322.9%)
Sep 2011
-
-7.12%(-181.5%)
Jun 2011
-
8.74%(-59.4%)
Mar 2011
-
21.52%(+114.3%)
Dec 2010
8.32%
10.04%(+74.6%)
DateAnnualQuarterly
Sep 2010
-
5.75%(-75.5%)
Jun 2010
-
23.43%(-682.8%)
Mar 2010
-
-4.02%(-96.9%)
Dec 2009
-1.59%(-98.1%)
-130.99%(>+9900.0%)
Sep 2009
-
-0.28%(-100.7%)
Jun 2009
-
38.44%(+462.0%)
Mar 2009
-
6.84%(-103.6%)
Dec 2008
-85.13%(+111.2%)
-189.92%(+239.4%)
Sep 2008
-
-55.96%(-25.1%)
Jun 2008
-
-74.70%(+4.6%)
Mar 2008
-
-71.44%(+5.5%)
Dec 2007
-40.30%(+389.7%)
-67.73%(-33.5%)
Sep 2007
-
-101.90%(+380.4%)
Jun 2007
-
-21.21%(+838.5%)
Mar 2007
-
-2.26%(-88.4%)
Dec 2006
-8.23%(+288.2%)
-19.48%(+54.4%)
Sep 2006
-
-12.62%(+3405.6%)
Jun 2006
-
-0.36%(-93.7%)
Mar 2006
-
-5.70%(-128.5%)
Dec 2005
-2.12%(-89.6%)
20.02%(-205.1%)
Sep 2005
-
-19.05%(-293.6%)
Jun 2005
-
9.84%(-124.4%)
Mar 2005
-
-40.27%(+63.5%)
Dec 2004
-20.32%(-202.0%)
-24.63%(-76.2%)
Sep 2004
-
-103.48%(+984.7%)
Jun 2004
-
-9.54%(-147.5%)
Mar 2004
-
20.07%(-212.8%)
Dec 2003
19.93%(+156.2%)
-17.79%(-125.7%)
Sep 2003
-
69.18%(+146.0%)
Jun 2003
-
28.12%(+261.0%)
Mar 2003
-
7.79%(-65.0%)
Dec 2002
7.78%(-125.8%)
22.27%(-22.1%)
Sep 2002
-
28.57%(+119.9%)
Jun 2002
-
12.99%(-119.7%)
Mar 2002
-
-65.89%(-192.2%)
Dec 2001
-30.11%(-73.4%)
71.45%(-390.4%)
Sep 2001
-
-24.60%(-76.3%)
Jun 2001
-
-103.69%(+47.2%)
Mar 2001
-
-70.46%(-95.5%)
Dec 2000
-113.23%(-58.9%)
-1558.48%(+8976.8%)
Sep 2000
-
-17.17%(-82.8%)
Jun 2000
-
-100.00%(-50.0%)
Mar 2000
-
-200.00%(-89.8%)
Dec 1999
-275.76%(-92.3%)
-1965.05%(+5795.7%)
Sep 1999
-
-33.33%(-66.7%)
Jun 1999
-
-100.00%(0.0%)
Mar 1999
-
-100.00%(-98.6%)
Dec 1998
-3575.00%(+315.3%)
-
Sep 1998
-
-7400.04%(>+9900.0%)
Jun 1998
-
-25.00%(-93.8%)
Mar 1998
-
-400.00%(-77.7%)
Dec 1997
-860.87%(+39.6%)
-1792.87%(+527.5%)
Sep 1997
-
-285.71%(-45.6%)
Jun 1997
-
-525.00%(+31.3%)
Mar 1997
-
-400.00%
Dec 1996
-616.67%
-

FAQ

  • What is COSCIENS Biopharma annual net profit margin?
  • What is the all time high annual net margin for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual net margin year-on-year change?
  • What is COSCIENS Biopharma quarterly net profit margin?
  • What is the all time high quarterly net margin for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly net margin year-on-year change?

What is COSCIENS Biopharma annual net profit margin?

The current annual net margin of CSCI is -48.89%

What is the all time high annual net margin for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual net profit margin is 46.14%

What is COSCIENS Biopharma annual net margin year-on-year change?

Over the past year, CSCI annual net profit margin has changed by -72.24% (-309.38%)

What is COSCIENS Biopharma quarterly net profit margin?

The current quarterly net margin of CSCI is -307.59%

What is the all time high quarterly net margin for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly net profit margin is 71.45%

What is COSCIENS Biopharma quarterly net margin year-on-year change?

Over the past year, CSCI quarterly net profit margin has changed by -185.33% (-151.59%)